• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于超小磁氧化铁纳米颗粒的活性氧物种循环加速用于肿瘤铁死亡治疗。

Cycloacceleration of Reactive Oxygen Species Generation Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for Tumor Ferroptosis Therapy.

机构信息

Guangdong Provincial Key Laboratory of Construction and Detection in Tissue Engineering, School of Basic Medical Sciences, Southern Medical University, 1023 Shatai South Road, Guangzhou, Guangdong, 510515, China.

Biomaterials Research Center, School of Biomedical Engineering, Southern Medical University, 1023 Shatai South Road, Guangzhou, Guangdong, 510515, China.

出版信息

Small. 2022 Sep;18(35):e2202705. doi: 10.1002/smll.202202705. Epub 2022 Aug 3.

DOI:10.1002/smll.202202705
PMID:35923138
Abstract

Because of the insufficiency of hydrogen peroxide, the relatively low rate of Fenton reaction, and the active glutathione (GSH) peroxidase 4 (GPX4) in tumor cells, it is difficult to achieve a desirable efficacy of ferroptosis therapy (FT) for tumors based on nanomaterials. Inspired by the concept of "cyclotron" in physics, in this study, a new concept of cycloacceleration of reactive oxygen species (ROS) generation in tumor cells to realize high-performance FT of tumors is proposed. Typically, a magnetic resonance imaging (MRI) contrast agent of dotted core-shell Fe O /Gd O hybrid nanoparticles (FGNPs) is prepared based on exceedingly small magnetic iron oxide nanoparticles (ES-MIONs). Sorafenib (SFN) is loaded and poly(ethylene glycol) methyl ether-poly(propylene sulfide)-NH (mPEG-PPS-NH ) is grafted on the surface of FGNP to generate SA-SFN-FGNP via self-assembly. The results of in vitro and in vivo demonstrate SA-SFN-FGNP can work with the acidic tumor microenvironment and endosomal conditions, Fenton reaction and system X , and generate cyclic reactions in tumor cells, resulting in specific cycloacceleration of ROS generation for high-performance FT of tumors. The very high longitudinal relaxivity (r , 33.43 mM s , 3.0 T) makes sure that the SA-SFN-FGNP can be used for MRI-guided FT of tumors.

摘要

由于过氧化氢的不足、芬顿反应的相对较低速率以及肿瘤细胞中活性谷胱甘肽 (GSH) 过氧化物酶 4 (GPX4) 的存在,基于纳米材料难以实现理想的铁死亡治疗 (FT) 效果。受物理“回旋加速器”概念的启发,本研究提出了一种新的肿瘤细胞中活性氧 (ROS) 生成的“回旋加速”概念,以实现肿瘤的高性能 FT。通常,基于非常小的磁性氧化铁纳米粒子 (ES-MIONs) 制备具有点核壳结构的 FeO/GdO 杂化纳米粒子 (FGNPs) 的磁共振成像 (MRI) 造影剂。负载索拉非尼 (SFN) 并在 FGNP 表面接枝聚乙二醇甲基醚-聚丙硫醚-NH(mPEG-PPS-NH),通过自组装生成 SA-SFN-FGNP。体外和体内结果表明,SA-SFN-FGNP 可以与酸性肿瘤微环境和内体条件、芬顿反应和系统 X 一起工作,并在肿瘤细胞中产生循环反应,从而实现 ROS 生成的特异性回旋加速,以实现肿瘤的高性能 FT。非常高的纵向弛豫率 (r1,33.43 mM s-1,3.0 T) 确保了 SA-SFN-FGNP 可用于 MRI 引导的肿瘤 FT。

相似文献

1
Cycloacceleration of Reactive Oxygen Species Generation Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for Tumor Ferroptosis Therapy.基于超小磁氧化铁纳米颗粒的活性氧物种循环加速用于肿瘤铁死亡治疗。
Small. 2022 Sep;18(35):e2202705. doi: 10.1002/smll.202202705. Epub 2022 Aug 3.
2
A Strategy of Fenton Reaction Cycloacceleration for High-Performance Ferroptosis Therapy Initiated by Tumor Microenvironment Remodeling.基于肿瘤微环境重塑的芬顿反应循环加速的高性能铁死亡治疗策略。
Adv Healthc Mater. 2023 Jul;12(18):e2203362. doi: 10.1002/adhm.202203362. Epub 2023 Mar 17.
3
An AND Logic Gate for Magnetic-Resonance-Imaging-Guided Ferroptosis Therapy of Tumors.一种用于磁共振成像引导肿瘤铁死亡治疗的与逻辑门。
Adv Mater. 2023 Nov;35(45):e2305932. doi: 10.1002/adma.202305932. Epub 2023 Oct 8.
4
Tumor-Generated Reactive Oxygen Species Storm for High-Performance Ferroptosis Therapy.肿瘤生成的活性氧物种风暴用于高性能铁死亡治疗。
ACS Nano. 2023 Jun 27;17(12):11492-11506. doi: 10.1021/acsnano.3c01369. Epub 2023 Jun 7.
5
Complementing Cancer Photodynamic Therapy with Ferroptosis through Iron Oxide Loaded Porphyrin-Grafted Lipid Nanoparticles.通过负载氧化铁的卟啉接枝脂质纳米颗粒来补充癌症光动力治疗中的铁死亡。
ACS Nano. 2021 Dec 28;15(12):20164-20180. doi: 10.1021/acsnano.1c08108. Epub 2021 Dec 13.
6
A mesoporous superparamagnetic iron oxide nanoparticle as a generic drug delivery system for tumor ferroptosis therapy.一种介孔超顺磁性氧化铁纳米颗粒作为用于肿瘤铁死亡治疗的通用药物递送系统。
J Nanobiotechnology. 2024 Apr 24;22(1):204. doi: 10.1186/s12951-024-02457-w.
7
A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis.一种具有氧化应激放大作用的肿瘤微环境响应型纳米平台,用于基于 MRI 的有效肿瘤铁死亡可视化。
Acta Biomater. 2022 Jan 15;138:518-527. doi: 10.1016/j.actbio.2021.11.007. Epub 2021 Nov 11.
8
Exceedingly Small Magnetic Iron Oxide Nanoparticles for T -Weighted Magnetic Resonance Imaging and Imaging-Guided Therapy of Tumors.用于T加权磁共振成像及肿瘤成像引导治疗的超小磁性氧化铁纳米颗粒
Small. 2023 Dec;19(49):e2302856. doi: 10.1002/smll.202302856. Epub 2023 Aug 18.
9
An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy.一种一体化仿生铁小分子干扰 RNA 纳米平台诱导铁死亡用于癌症治疗。
Acta Biomater. 2022 Aug;148:244-257. doi: 10.1016/j.actbio.2022.06.017. Epub 2022 Jun 13.
10
Multivalent Polypeptide and Tannic Acid Cooperatively Iron-Coordinated Nanohybrids for Synergistic Cancer Photothermal Ferroptosis Therapy.多价多肽和鞣酸协同铁配位纳米杂化物用于协同癌症光热铁死亡治疗。
Biomacromolecules. 2022 Jun 13;23(6):2655-2666. doi: 10.1021/acs.biomac.2c00409. Epub 2022 May 18.

引用本文的文献

1
Recent Advancement in MRI-Based Nanotheranostic Agents for Tumor Diagnosis and Therapy Integration.基于磁共振成像的肿瘤诊断与治疗一体化纳米诊疗剂的最新进展
Int J Nanomedicine. 2025 Aug 29;20:10503-10540. doi: 10.2147/IJN.S529003. eCollection 2025.
2
Advances in nanocarrier-mediated cancer therapy: Progress in immunotherapy, chemotherapy, and radiotherapy.纳米载体介导的癌症治疗进展:免疫疗法、化学疗法和放射疗法的进展
Chin Med J (Engl). 2025 Aug 20;138(16):1927-1944. doi: 10.1097/CM9.0000000000003703. Epub 2025 Jun 23.
3
Anticancer therapeutic potential of multimodal targeting agent- "phosphorylated galactosylated chitosan coated magnetic nanoparticles" against N-nitrosodiethylamine-induced hepatocellular carcinoma.
多模态靶向剂“磷酸化半乳糖基化壳聚糖包被磁性纳米颗粒”对N-亚硝基二乙胺诱导的肝细胞癌的抗癌治疗潜力
Drug Deliv Transl Res. 2025 Mar;15(3):1023-1042. doi: 10.1007/s13346-024-01655-1. Epub 2024 Jul 11.
4
Iron oxide nanoparticles in magnetic drug targeting and ferroptosis-based cancer therapy.磁性药物靶向和铁死亡介导的癌症治疗中的氧化铁纳米颗粒
Med Rev (2021). 2023 Sep 20;3(5):444-447. doi: 10.1515/mr-2023-0029. eCollection 2023 Oct.
5
Recent Advances in Targeted Drug Delivery Strategy for Enhancing Oncotherapy.增强肿瘤治疗的靶向给药策略的最新进展
Pharmaceutics. 2023 Aug 29;15(9):2233. doi: 10.3390/pharmaceutics15092233.
6
Prognostic and therapeutic implications of iron-related cell death pathways in acute myeloid leukemia.铁相关细胞死亡途径在急性髓系白血病中的预后和治疗意义
Front Oncol. 2023 Sep 5;13:1222098. doi: 10.3389/fonc.2023.1222098. eCollection 2023.
7
Superparamagnetic iron oxide nanoparticles for their application in the human body: Influence of the surface.用于人体的超顺磁性氧化铁纳米颗粒:表面的影响
Heliyon. 2023 May 25;9(6):e16487. doi: 10.1016/j.heliyon.2023.e16487. eCollection 2023 Jun.
8
PHGDH Inhibitor CBR-5884 Inhibits Epithelial Ovarian Cancer Progression via ROS/Wnt/-Catenin Pathway and Plays a Synergistic Role with PARP Inhibitor Olaparib.PHGDH 抑制剂 CBR-5884 通过 ROS/Wnt/-Catenin 通路抑制卵巢上皮性癌细胞进展,并与 PARP 抑制剂奥拉帕利发挥协同作用。
Oxid Med Cell Longev. 2022 Sep 5;2022:9029544. doi: 10.1155/2022/9029544. eCollection 2022.